Injections, Subcutaneous

I LAGH (ormoni della crescita long-acting): cosa sono e a chi proporli?

Rodaro C, Tornese G.

2024/6 — pag. 371-375 — DOI

Children with growth hormone deficiency are currently treated with daily injections of recombinant growth hormone. The burden of 365 injections per year and cold chain storage causes a poor medication adherence. Long-acting growth hormones were devel...

Immunoterapia sublinguale vs sottocutanea nelle malattie allergiche respiratorie:tutta l'evidenza nient'altro che l'evidenza (in modo schematico).

D. Radzik

2006/2

Immunoterapia sublinguale vs sottocutanea nelle malattie allergiche respiratorie:tutta l'evidenza nient'altro che l'evidenza (in modo schematico).

D. Radzik

2006/2

L’immunoterapia specifica orale: sì o no?

G. Longo

2001/9 — pag. 617-620

Desensitization through the sublingual route is very popular and covers about 50% of the market. There is general consensus on its biological efficacy but at a more careful scrutiny its widespread use does not appear totally justified. If costs, li...